Buy BDTX by Jun 30, 2025.

Black Diamond Therapeutics (BDTX) is a clinical stage company developing MasterKey therapies (targeting a wide array of variations) against tumours and cancers in brain and lungs. The company has 1 drug under development, for different types of patients, currently under Phase 2 development, likely to move into Phase 3/FDA approval request by H1 of next year. It had another drug candidate it had just begun developing, which was on Phase 1 trials. 10 days ago it signed a deal to …